Literature DB >> 19679552

IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacity.

Maria Pletneva1, Hongni Fan, Jang-June Park, Vedran Radojcic, Chunfa Jie, Yanxing Yu, Camie Chan, Alec Redwood, Drew Pardoll, Franck Housseau.   

Abstract

IFN-producing killer dendritic cells (IKDC) represent a recently discovered cell type in the immune system that possesses a number of functions contributing to innate and adaptive immunity, including production of type 1 and 2 IFNs, interleukin (IL)-12, natural killing, and ultimately antigen presentation to naïve T cells. Here, we compared in vitro and in vivo responses of mouse IKDC, conventional dendritic cells (DC), and natural killer (NK) cells to murine cytomegalovirus infection and found distinct functions among these cell subsets. Upon recognition of infected fibroblasts, IKDC, as well as NK, produced high level of IFN-gamma, but unlike NK, IKDC simultaneously produced IL-12p40 and up-regulated MHC class II (MHC-II) and costimulatory molecules. Using MHC-II molecule expression as a phenotypic marker to distinguish activated IKDC from activated NK, we further showed that highly purified MHC-II(+) IKDC but not NK cross-present MHC class I-restricted antigens derived from MCMV-infected targets to CD8(+) T cells in vitro and in vivo. Our findings emphasize the unique nature of IKDC as a killer antigen-presenting cell directly linking innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679552      PMCID: PMC2761009          DOI: 10.1158/0008-5472.CAN-09-0508

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  The nature of the MHC class I peptide loading complex.

Authors:  P Cresswell; N Bangia; T Dick; G Diedrich
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

2.  Activation of lysosomal function during dendritic cell maturation.

Authors:  E Sergio Trombetta; Melanie Ebersold; Wendy Garrett; Marc Pypaert; Ira Mellman
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

Review 3.  Endocytosis mechanisms and the cell biology of antigen presentation.

Authors:  Sven Burgdorf; Christian Kurts
Journal:  Curr Opin Immunol       Date:  2008-01-30       Impact factor: 7.486

4.  IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo.

Authors:  Claudia Papewalis; Benedikt Jacobs; Margret Wuttke; Evelyn Ullrich; Thomas Baehring; Roland Fenk; Holger S Willenberg; Sven Schinner; Mathias Cohnen; Jochen Seissler; Kai Zacharowski; Werner A Scherbaum; Matthias Schott
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

5.  Neutrophils efficiently cross-prime naive T cells in vivo.

Authors:  Céline Beauvillain; Yves Delneste; Mari Scotet; Audrey Peres; Hugues Gascan; Pierre Guermonprez; Vincenzo Barnaba; Pascale Jeannin
Journal:  Blood       Date:  2007-06-11       Impact factor: 22.113

Review 6.  The 'kiss of death' by dendritic cells to cancer cells.

Authors:  C W Chan; F Housseau
Journal:  Cell Death Differ       Date:  2007-10-19       Impact factor: 15.828

7.  Antigen crosspresentation by human plasmacytoid dendritic cells.

Authors:  Guillaume Hoeffel; Anne-Claire Ripoche; Diana Matheoud; Michelina Nascimbeni; Nicolas Escriou; Pierre Lebon; Farhad Heshmati; Jean-Gérard Guillet; Monique Gannagé; Sophie Caillat-Zucman; Nicoletta Casartelli; Olivier Schwartz; Henri De la Salle; Daniel Hanau; Anne Hosmalin; Concepción Marañón
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

8.  CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells.

Authors:  Christian A J Vosshenrich; Sarah Lesjean-Pottier; Milena Hasan; Odile Richard-Le Goff; Erwan Corcuff; Ofer Mandelboim; James P Di Santo
Journal:  J Exp Med       Date:  2007-10-08       Impact factor: 14.307

9.  Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells.

Authors:  Amanda L Blasius; Winfried Barchet; Marina Cella; Marco Colonna
Journal:  J Exp Med       Date:  2007-10-08       Impact factor: 14.307

10.  Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells.

Authors:  Irina Caminschi; Fatma Ahmet; Klaus Heger; Jason Brady; Stephen L Nutt; David Vremec; Suzanne Pietersz; Mireille H Lahoud; Louis Schofield; Diana S Hansen; Meredith O'Keeffe; Mark J Smyth; Sammy Bedoui; Gayle M Davey; Jose A Villadangos; William R Heath; Ken Shortman
Journal:  J Exp Med       Date:  2007-10-08       Impact factor: 14.307

View more
  12 in total

1.  KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production.

Authors:  Jeremy A Goettel; Holly M Scott Algood; Danyvid Olivares-Villagómez; M Kay Washington; Rupesh Chaturvedi; Keith T Wilson; Luc Van Kaer; D Brent Polk
Journal:  Gastroenterology       Date:  2010-09-25       Impact factor: 22.682

2.  Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE.

Authors:  Eduardo Huarte; Agnieszka Rynda-Apple; Carol Riccardi; Jerod A Skyberg; Sarah Golden; Maryclare F Rollins; Andrew G Ramstead; Larissa O Jackiw; Massimo Maddaloni; David W Pascual
Journal:  J Autoimmun       Date:  2011-10-22       Impact factor: 7.094

Review 3.  Designing CD8+ T cell vaccines: it's not rocket science (yet).

Authors:  Jonathan W Yewdell
Journal:  Curr Opin Immunol       Date:  2010-05-04       Impact factor: 7.486

4.  Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus.

Authors:  Elisaveta N Voynova; Jeffrey Skinner; Silvia Bolland
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

Review 5.  Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

Authors:  Antonella Sistigu; Sophie Viaud; Nathalie Chaput; Laura Bracci; Enrico Proietti; Laurence Zitvogel
Journal:  Semin Immunopathol       Date:  2011-05-25       Impact factor: 11.759

6.  Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.

Authors:  Han-Xian Gong; Lei He; Xiang-Pen Li; Yi-Dong Wang; Yi Li; Jun-Jian Huang; Ziling Wang; Dan Xie; Hsiang-Fu Kung; Ying Peng
Journal:  Oncol Rep       Date:  2011-12-30       Impact factor: 3.906

7.  Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.

Authors:  Luyu Yao; Xiaobo Yan; Huijia Dong; David R Nelson; Chen Liu; Xiaoyu Li
Journal:  Virol J       Date:  2011-09-21       Impact factor: 4.099

8.  Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases.

Authors:  Kelly Olino; Satoshi Wada; Barish H Edil; Xiaoyu Pan; Kristen Meckel; Walter Weber; Jill Slansky; Koji Tamada; Peter Lauer; Dirk Brockstedt; Drew Pardoll; Richard Schulick; Kiyoshi Yoshimura
Journal:  Ann Surg Oncol       Date:  2011-10-07       Impact factor: 5.344

9.  Burn injury triggered dysfunction in dendritic cell response to TLR9 activation and resulted in skewed T cell functions.

Authors:  Haitao Shen; Patricia E de Almeida; Kyung H Kang; Pamela Yao; Camie W Chan
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

10.  Depletion of B220+NK1.1+ cells enhances the rejection of established melanoma by tumor-specific CD4+ T cells.

Authors:  Kyle A Wilson; Stephen R Goding; Harold R Neely; Kristina M Harris; Paul Andrew Antony
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.